A novel approach to iboga alkaloids: Total synthesis of (±)-ibogamine and (±)-epi-ibogamine

DOI: 10.1016/0040-4039(96)01939-9

Source and publish data:

Tetrahedron Letters p. 8289 - 8292 (1996)

Update date:2022-08-05

Topics:

Authors:

Henry Jr., Kenneth J.

Grieco, Paul A.

DuBay, William J.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1016/0040-4039(96)01939-9

A novel approach to the total synthesis of (±)-ibogamine and (±)-epi-ibogamine, featuring electrophilic substitution at C(2) of N'-CBZ-tryptamine by an allylic acetate, is described.

Full text of DOI:10.1016/0040-4039(96)01939-9

Products guided by the article

Product name:(+/-)-epi-ibogamine

Cas No:72748-33-5

R&D Labs maybe for 72748-33-5

Chengda Pharmaceuticals Co., Ltd.

Contact:+86-573-84601188

Address:hengshan Road 5# in Jiashan, zhejiang
FUJIAN SHANSHUI CHEMICAL CORP.LTD.

Contact:+86-151-59920036

Address:Jinqiao Gareden, jo@fj-xinyi.com
Chengdu ZY Biochemical Technology Co., LTD

Contact:0086-28-88680086

Address:170 Qingpu Road, Shouan Town, Pujiang County
Hebei yanxi chemical co.,LTD.

website:https://en.yan-xi.com/

Contact:+86 17531153977

Address:Zhang zhe, guangzong county, xingtai city, hebei province
Shanghai Korey Pharm Co.,Ltd.(expird)

Contact:021-61840961 021-61840962

Address:No.157,Zhuguang Rd, Qingpu, Shanghai, China

Relevant to this article

Doi:10.1021/ja01152a539
(1951)
SYNTHESIS AND INFRARED STUDY OF (C6H5)_nPX_3-nCr(CO)5 (X=Cl, Br, I, H; n=0-3) AND (C6H5)2PRCr(CO)5 (R=METHYL, ETHYL, i-PROPYL, t-BUTYL) COMPOUNDS

Doi:10.1016/0022-2860(80)85261-6
(1980)
Design and synthesis of β-amino-α-hydroxy amide derivatives as inhibitors of MetAP2 and HUVEC growth

Doi:10.1016/j.bmcl.2004.04.004
(2004)
Syntheses of (+)- and (-)-dihydropinidine and (+)- and (-)- epidihydropinidine by using yeast reduction of methyl (2-oxocyclohexyl)acetate

Doi:10.1271/bbb.68.676
(2004)
Dimethyl sulfoxide ruthenium(II) complexes of thiosemicarbazones and semicarbazone: Synthesis, characterization and biological studies

Doi:10.1016/j.poly.2008.05.034
(2008)
(+/-)-3-Allyl-6-bromo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepin, a New High-Affinity D1 Dopamine Receptor Ligand: Synthesis and Structure-Activity Relationship

Doi:10.1021/jm00116a004
(1991)

Article Doi